Welcome to our Clinical Trial draft guidance feedback survey.
In developing this new draft guidance, we have had input on content and wording from experts and representatives from commercial and non-commercial sectors to ensure we have set out comprehensive draft guidance.
This questionnaire offers you the opportunity to provide your views about the guidance, or to feedback on each section.
We are interested in hearing your views on the accuracy and clarity of the draft guidance and whether it is clear, easy to understand and implement.
We will not be able to act on feedback that relates to the content of the Medicines for Human Use (Clinical Trials) Regulations that this guidance accompanies.
Unfortunately, we are unable to accept feedback submitted via any route other than through this questionnaire.
The deadline for feedback is 11.59pm on 30 July 2025.
Responses and feedback will then be aggregated, themed and prioritised. We won’t respond directly to individual questions and comments submitted in the questionnaire, but we may contact you if we need more information on any points you have raised.
Your personal information will be treated in confidence. Full details of how your information will be used are included in our privacy notice.